| Lot | A7071-001P |
|---|---|
| Concentration | 1.2 µg/µl |
| Species reactivity | Human, mouse, rat, pig: positive. Other species: not tested. |
| Type | Polyclonal, ChIP-grade, ChIP-seq grade |
| Purity | Affinity purified polyclonal antibody. |
| Host | Rabbit |
| Storage Conditions | Store at -20°C; for long storage, store at -80°C. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | PBS containing 0.05% azide and 0.05% ProClin 300. |
| Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
| Applications | Suggested dilution | References |
|---|---|---|
| ChIP/ChIP-seq * | 1-2 µg/ChIP | Fig 1, 2 |
| ELISA | 1:500 | Fig 3 |
| Dot Blotting | 1:25,000 | Fig 4 |
| Western Blotting | 1:1,000 | Fig 5 |
| Immunofluorescence | 1:500 | Fig 6 |
* Please note that the optimal antibody amount per IP should be determined by the end-user. We recommend testing 1-5 µg per IP.

Figure 1. ChIP results obtained with the antibody directed against H3K27ac
ChIP was performed on sheared chromatin from 1 million HeLa cells using the antibody against H3K27ac (cat. No. C15410174) and optimized PCR primer sets for qPCR. A titration of the antibody consisting of 1, 2, 5, and 10 µg per ChIP experiment was analyzed. IgG (2 µg/IP) was used as a negative IP control. Quantitative PCR was performed using primers for the promoters of the active ACTB and EIF4A2 genes (used as positive controls), and for the coding region of the inactive MYT1 and TSH2B genes (used as negative controls). Figure 1 shows the recovery expressed as a % of input (the relative amount of immunoprecipitated DNA compared to input DNA after qPCR analysis). These results are consistent with the observation that H3K27 acetylation is enriched at the promoters of active genes.
A

Figure 2. ChIP-seq results obtained with the antibody directed against H3K27ac
ChIP was performed on sheared chromatin from 1 million HeLaS3 cells using 2 µg of the antibody against H3K27ac (cat. No. C15410174) as described above. Quantitative PCR analysis was performed with primers for the promoters of the active ACTB and EIF4A2 genes (used as positive controls), and for the coding region of the inactive MYT1 and MB genes (used as negative controls (Figure 2A)). The IP’d DNA was subsequently analyzed on an Illumina Genome Analyzer. Library preparation, cluster generation, and sequencing were performed according to the manufacturer’s instructions. The 36 bp tags were aligned to the human genome using the ELAND algorithm. Figure 2B shows the peak distribution along the complete X chromosome and in two regions surrounding the ACTB and EIF4A2 positive control genes, respectively (Figure 2C and 2D).

Figure 3. Determination of the antibody titer
To determine the titer of the antibody, an ELISA was performed using a serial dilution of the antibody directed against H3K27ac (cat. No. C15410174) in antigen-coated wells. The antigen used was a peptide containing the histone modification of interest. By plotting the absorbance against the antibody dilution (Figure 3), the titer of the antibody was estimated to be 1:5,500.

Figure 4. Cross reactivity test using the antibody directed against H3K27ac
A Dot Blot analysis was performed to test the cross-reactivity of the antibody against H3K27ac (cat. No. C15410174) with peptides containing other histone modifications and the unmodified H3K27 sequence. One hundred to 0.2 pmol of the respective peptides were spotted on a membrane. The antibody was used at a dilution of 1:25,000. Figure 4 shows a high specificity of the antibody for the modification of interest.

Figure 5. Western blot analysis using the antibody directed against H3K27ac
Western blot was performed on whole-cell extracts (40 µg, lane 1) and histone extracts (15 µg, lane 2) from HeLa cells, as well as on 1 µg of recombinant histones H2A, H2B, H3, and H4 (lane 3, 4, 5, and 6, respectively) using the antibody against H3K27ac (cat. No. C15410174). The antibody was diluted 1:1,000 in TBS-Tween containing 5% skimmed milk. The position of the protein of interest is indicated on the right; the marker (in kDa) is shown on the left.

Figure 6. Immunofluorescence using the antibody directed against H3K27ac
HeLa cells were stained with the antibody against H3K27ac (cat. No. C15410174) and with DAPI. Cells were fixed with 4% formaldehyde for 10’ and blocked with PBS/TX-100 containing 5% normal goat serum and 1% BSA. The cells were immunofluorescently labeled with the H3K27ac antibody (left) diluted 1:500 in blocking solution followed by an anti-rabbit antibody conjugated to Alexa488. The middle panel shows staining of the nuclei with DAPI. A merge of the two stains is shown on the right.
Histones are the main constituents of the protein part of chromosomes of eukaryotic cells. They are rich in the amino acids arginine and lysine and have been greatly conserved during evolution. Histones pack the DNA into tight masses of chromatin. Two core histones of each class H2A, H2B, H3 and H4 assemble and are wrapped by 146 base pairs of DNA to form one octameric nucleosome. Histone tails undergo numerous post-translational modifications, which either directly or indirectly alter chromatin structure to facilitate transcriptional activation or repression or other nuclear processes. In addition to the genetic code, combinations of the different histone modifications reveal the so-called “histone code”. Histone methylation and demethylation is dynamically regulated by respectively histone methyl transferases and histone demethylases.
| ELISA Enzyme-linked immunosorbent assay. Read more |
| DB Dot blotting Read more |
| WB Western blot : The quality of antibodies used in this technique is crucial for correct and specific protein identification. Diagenode offers huge selection of highly sensitive and specific western blot-validated antibodies. Learn more about: Load... Read more |
| IF Immunofluorescence: Diagenode offers huge selection of highly sensitive antibodies validated in IF. Immunofluorescence using the Diagenode monoclonal antibody directed against CRISPR/Cas9 HeLa cells transfected with a Cas9 expression vector (... Read more |
| ChIP-seq (ab) Read more |
| ChIP-qPCR (ab) Read more |
| Datasheet H3K27ac DATASHEET Polyclonal antibody raised in rabbit against histone H3, acetylated at lysine 27 (H3K27ac), using... | Download |
| Epigenetic Antibodies Brochure BROCHURE More than in any other immuoprecipitation assays, quality antibodies are critical tools in many e... | Download |
| Antibodies you can trust POSTER Epigenetic research tools have evolved over time from endpoint PCR to qPCR to the analyses of lar... | Download |
| SDS C15410174 H3K27ac Antibody US en | Download |
| SDS C15410174 H3K27ac Antibody GB en | Download |
| SDS C15410174 H3K27ac Antibody DE de | Download |
| SDS C15410174 H3K27ac Antibody BE fr | Download |
| SDS C15410174 H3K27ac Antibody ES es | Download |
| SDS C15410174 H3K27ac Antibody FR fr | Download |
| SDS C15410174 H3K27ac Antibody JP ja | Download |
| SDS C15410174 H3K27ac Antibody BE nl | Download |
How to properly cite our product/service in your workWe strongly recommend using this: H3K27ac Antibody (Hologic Diagenode Cat# C15410174 Lot# A7071-001P). Click here to copy to clipboard. Using our products or services in your publication? Let us know! |
Multimodal epigenetic and enhancer network remodeling shape the transcriptional landscape of human beige adipocytes |
Liebenberg syndrome severity arises from variations in Pitx1 locus topology and proportion of ectopically transcribing cells |
Incomplete transcriptional dosage compensation of vertebrate sexchromosomes is balanced by post-transcriptional compensation |
Gene Regulatory Interactions at Lamina-Associated Domains |
Repression and 3D-restructuring resolves regulatory conflicts inevolutionarily rearranged genomes. |
Epigenetic remodeling of downstream enhancer regions is linked toselective expression of the IL1F10 gene in differentiated humankeratinocytes. |
HOTAIR interacts with PRC2 complex regulating the regional preadipocytetranscriptome and human fat distribution. |
Nox4 promotes endothelial differentiation through chromatin remodeling. |
Local euchromatin enrichment in lamina-associated domains anticipatestheir repositioning in the adipogenic lineage. |
Screening of ETO2-GLIS2-induced Super Enhancers identifiestargetable cooperative dependencies in acute megakaryoblastic leukemia. |
Loss of KMT2C reprograms the epigenomic landscape in hPSCsresulting in NODAL overexpression and a failure of hemogenic endotheliumspecification. |
SETD2-mediated epigenetic regulation of noncanonical Wnt5A duringosteoclastogenesis |
Activated Histone Acetyltransferase p300/CBP-Related SignallingPathways Mediate Up-Regulation of NADPH Oxidase,Inflammation, and Fibrosis in Diabetic Kidney |
Cell-specific alterations inPitx1regulatory landscape activation caused bythe loss of a single enhancer |
Functional annotations of three domestic animal genomes provide vitalresources for comparative and agricultural research. |
A Tumor Suppressor Enhancer of PTEN in T-cell development and leukemia |
EZH2 and KDM6B Expressions Are Associated with Specific EpigeneticSignatures during EMT in Non Small Cell Lung Carcinomas. |
Enhancer hijacking determines extrachromosomal circular MYCN ampliconarchitecture in neuroblastoma. |
ΔNp63 is a pioneer factor that binds inaccessible chromatin and elicitchromatin remodeling |
Distinct and temporary-restricted epigenetic mechanisms regulate human αβ and γδ T cell development |
HDAC3 functions as a positive regulator in Notch signal transduction. |
Long non-coding RNA uc.291 controls epithelial differentiation by interfering with the ACTL6A/BAF complex. |
Distinct IL-1α-responsive enhancers promote acute and coordinated changes in chromatin topology in a hierarchical manner. |
Functional dissection of the Sox9-Kcnj2 locus identifies nonessential and instructive roles of TAD architecture. |
Elevated cyclic-AMP represses expression of exchange protein activated by cAMP (EPAC1) by inhibiting YAP-TEAD activity and HDAC-mediated histone deacetylation. |
Preformed chromatin topology assists transcriptional robustness of during limb development. |
Point mutations in the PDX1 transactivation domain impair human β-cell development and function. |
Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia. |
Mutant p63 Affects Epidermal Cell Identity through Rewiring the Enhancer Landscape. |
Deletion of an intronic HIF-2α binding site suppresses hypoxia-induced WT1 expression. |
Sequentially acting SOX proteins orchestrate astrocyte- and oligodendrocyte-specific gene expression. |
Histone variant H2A.Z deposition and acetylation directs the canonical Notch signaling response. |
Epigenetic regulation of vascular NADPH oxidase expression and reactive oxygen species production by histone deacetylase-dependent mechanisms in experimental diabetes. |
HMGB2 Loss upon Senescence Entry Disrupts Genomic Organization and Induces CTCF Clustering across Cell Types. |
Genome-wide analysis of PDX1 target genes in human pancreatic progenitors. |
A lipodystrophy-causing lamin A mutant alters conformation and epigenetic regulation of the anti-adipogenic MIR335 locus |
Chromatin Immunoprecipitation (ChIP) in Mouse T-cell Lines |
Evolutionary re-wiring of p63 and the epigenomic regulatory landscape in keratinocytes and its potential implications on species-specific gene expression and phenotypes |
Chd7 is indispensable for mammalian brain development through activation of a neuronal differentiation programme |
MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia. |
Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer |
Phenotypic Plasticity through Transcriptional Regulation of the Evolutionary Hotspot Gene tan in Drosophila melanogaster |
Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies |
Genome-wide p63-regulated gene expression in differentiating epidermal keratinocytes |
Spatiotemporal control of estrogen-responsive transcription in ERα-positive breast cancer cells. |
Transcription factor p63 bookmarks and regulates dynamic enhancers during epidermal differentiation |
The Activation of IL-1-Induced Enhancers Depends on TAK1 Kinase Activity and NF-κB p65. |
Nitric oxide-induced neuronal to glial lineage fate-change depends on NRSF/REST function in neural progenitor cells. |
A novel microscopy-based high-throughput screening method to identify proteins that regulate global histone modification levels. |